Neo-Angin Dolo Spray 8.75 mg

Neo-Angin Dolo Spray 8.75 mg is a medicine authorised by Swissmedic under authorisation number 67471. The authorisation holder is Doetsch Grether AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 30 September 2019 and the authorisation is valid without a time limit. ATC code R02AX01 places the medicine in the group Throat preparations.

  • Dispensing category D
  • Authorisation number 67471
  • ATC R02AX01
  • Synthetic medicines
Authorisation data
Authorisation number67471
NameNeo-Angin Dolo Spray 8.75 mg
Full nameNeo-Angin Dolo Spray 8.75 mg, Spray zur Anwendung in der Mundhöhle, Lösung mit Kirscharoma
Authorisation holderDoetsch Grether AG
Medicinal product codeSynthetic medicines
Dispensing categoryD · No prescription, with advice
ATC codeR02AX01
First authorisation30 September 2019
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Neo-Angin Dolo Spray 8.75 mg, Spray zur Anwendung in der Mundhöhle, Lösung mit KirscharomaD30 September 2019

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
115mlR02AX0112.03.2.D

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Neo-Angin Dolo Spray 8.75 mg authorised in Switzerland?

Yes. Neo-Angin Dolo Spray 8.75 mg is authorised by Swissmedic under authorisation number 67471, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Neo-Angin Dolo Spray 8.75 mg have?

Neo-Angin Dolo Spray 8.75 mg is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.

Who is the authorisation holder of Neo-Angin Dolo Spray 8.75 mg?

The authorisation holder is Doetsch Grether AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com